Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P L Collins

Showing results (131-140 of 160) with videos related to

Pageof 16
Sort By:
Vaccine|April 1, 1990
Evaluation in chimpanzees of vaccinia virus recombinants that express the surface glycoproteins of human respiratory syncytial virusP L Collins, R H Purcell, W T London, et al.
Journal of Virology|March 9, 2000
A recombinant human parainfluenza virus type 3 (PIV3) in which the nucleocapsid N protein has been replaced by that of bovine PIV3 is attenuated in primatesJ E Bailly, J M McAuliffe, A P Durbin, et al.
Archives of Virology|November 7, 1999
Rescue of a bovine respiratory syncytial virus genomic RNA analog by bovine, human and ovine respiratory syncytial viruses confirms the "functional integrity" and "cross-recognition" of BRSV cis-acting elements by HRSV and ORSVA S Yunus, S Krishnamurthy, M K Pastey, et al.
Vaccine|January 5, 2000
A live attenuated recombinant chimeric parainfluenza virus (PIV) candidate vaccine containing the hemagglutinin-neuraminidase and fusion glycoproteins of PIV1 and the remaining proteins from PIV3 induces resistance to PIV1 even in animals immune to PIV3T Tao, F Davoodi, C J Cho, et al.
The Journal of General Virology|March 1, 1993
Expression of the G glycoprotein gene of human respiratory syncytial virus in Salmonella typhimuriumA Martin-Gallardo, E Fleischer, S A Doyle, et al.
Journal of Virology|September 12, 2000
Recombinant respiratory syncytial virus that does not express the NS1 or M2-2 protein is highly attenuated and immunogenic in chimpanzeesM N Teng, S S Whitehead, A Bermingham, et al.
Journal of Virology|February 1, 1995
Cytotoxic T cells specific for a single peptide on the M2 protein of respiratory syncytial virus are the sole mediators of resistance induced by immunization with M2 encoded by a recombinant vaccinia virusA B Kulkarni, P L Collins, I Bacik, et al.
Journal of Virology|February 1, 1992
Resistance to respiratory syncytial virus (RSV) challenge induced by infection with a vaccinia virus recombinant expressing the RSV M2 protein (Vac-M2) is mediated by CD8+ T cells, while that induced by Vac-F or Vac-G recombinants is mediated by antibodiesM Connors, A B Kulkarni, P L Collins, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1986
Nucleotide sequences for the gene junctions of human respiratory syncytial virus reveal distinctive features of intergenic structure and gene orderP L Collins, L E Dickens, A Buckler-White, et al.
Journal of Virology|November 13, 1999
Replacement of the F and G proteins of respiratory syncytial virus (RSV) subgroup A with those of subgroup B generates chimeric live attenuated RSV subgroup B vaccine candidatesS S Whitehead, M G Hill, C Y Firestone, et al.
Pageof 16

Showing results (131-140 of 160) with videos related to

Sort By:
Pageof 16
Vaccine|April 1, 1990
Evaluation in chimpanzees of vaccinia virus recombinants that express the surface glycoproteins of human respiratory syncytial virusP L Collins, R H Purcell, W T London, et al.
Journal of Virology|March 9, 2000
A recombinant human parainfluenza virus type 3 (PIV3) in which the nucleocapsid N protein has been replaced by that of bovine PIV3 is attenuated in primatesJ E Bailly, J M McAuliffe, A P Durbin, et al.
Archives of Virology|November 7, 1999
Rescue of a bovine respiratory syncytial virus genomic RNA analog by bovine, human and ovine respiratory syncytial viruses confirms the "functional integrity" and "cross-recognition" of BRSV cis-acting elements by HRSV and ORSVA S Yunus, S Krishnamurthy, M K Pastey, et al.
Vaccine|January 5, 2000
A live attenuated recombinant chimeric parainfluenza virus (PIV) candidate vaccine containing the hemagglutinin-neuraminidase and fusion glycoproteins of PIV1 and the remaining proteins from PIV3 induces resistance to PIV1 even in animals immune to PIV3T Tao, F Davoodi, C J Cho, et al.
The Journal of General Virology|March 1, 1993
Expression of the G glycoprotein gene of human respiratory syncytial virus in Salmonella typhimuriumA Martin-Gallardo, E Fleischer, S A Doyle, et al.
Journal of Virology|September 12, 2000
Recombinant respiratory syncytial virus that does not express the NS1 or M2-2 protein is highly attenuated and immunogenic in chimpanzeesM N Teng, S S Whitehead, A Bermingham, et al.
Journal of Virology|February 1, 1995
Cytotoxic T cells specific for a single peptide on the M2 protein of respiratory syncytial virus are the sole mediators of resistance induced by immunization with M2 encoded by a recombinant vaccinia virusA B Kulkarni, P L Collins, I Bacik, et al.
Journal of Virology|February 1, 1992
Resistance to respiratory syncytial virus (RSV) challenge induced by infection with a vaccinia virus recombinant expressing the RSV M2 protein (Vac-M2) is mediated by CD8+ T cells, while that induced by Vac-F or Vac-G recombinants is mediated by antibodiesM Connors, A B Kulkarni, P L Collins, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1986
Nucleotide sequences for the gene junctions of human respiratory syncytial virus reveal distinctive features of intergenic structure and gene orderP L Collins, L E Dickens, A Buckler-White, et al.
Journal of Virology|November 13, 1999
Replacement of the F and G proteins of respiratory syncytial virus (RSV) subgroup A with those of subgroup B generates chimeric live attenuated RSV subgroup B vaccine candidatesS S Whitehead, M G Hill, C Y Firestone, et al.
Pageof 16